The MARCH family of membrane-bound E3 ubiquitin ligases comprises a group of proteins known for their role in the ubiquitination process, which marks proteins for degradation or alters their function. MARCH proteins are involved in the regulation of a variety of cellular processes, particularly those related to the immune system, such as antigen presentation and immune signaling. They function by adding ubiquitin molecules to specific target proteins, typically membrane proteins, leading to their internalization, trafficking, and sometimes degradation. This ubiquitination process is crucial for maintaining cellular homeostasis and regulating the abundance and activity of key cell surface receptors and molecules. MARCH family members, through their ligase activity, can influence signaling pathways, and their dysregulation is implicated in various diseases, including cancers and immune disorders. Additionally, the MARCH family plays a role in viral immune evasion, as some viruses have evolved MARCH-like proteins to downregulate immune molecules on the host cell surface.
Targeting the MARCH family of E3 ubiquitin ligases with small molecules for disruption or inhibition can significantly advance the understanding of their mechanistic roles in cellular processes. Inhibition of MARCH proteins allows for the study of how the controlled degradation and regulation of membrane proteins affect cell signaling and immune responses. By inhibiting the ubiquitination of specific target proteins, researchers can observe the resultant changes in cellular pathways, particularly in the context of immune cell activation and antigen presentation.
VER TAMBIÉN ....
Items 1 to 10 of 19 total
Mostrar:
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
La simvastatina inhibe la MARCH bloqueando la HMG-CoA reductasa, una enzima clave en la síntesis del colesterol, lo que provoca una reducción de los niveles de colesterol en las células. La reducción de los niveles de colesterol disminuye la activación de MARCH. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
La lovastatina, al igual que la simvastatina, inhibe la HMG-CoA reductasa, reduciendo los niveles celulares de colesterol e inhibiendo indirectamente la activación de MARCH. | ||||||
Pravastatin, Sodium Salt | 81131-70-6 | sc-203218 sc-203218A sc-203218B | 25 mg 100 mg 1 g | $68.00 $159.00 $772.00 | 2 | |
La pravastatina inhibe la síntesis de colesterol dirigiéndose a la HMG-CoA reductasa, lo que puede afectar a la activación de MARCH debido a la reducción de los niveles de colesterol. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
La atorvastatina inhibe la HMG-CoA reductasa, reduciendo la producción de colesterol e inhibiendo posteriormente la activación de MARCH. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $142.00 | 8 | |
La rosuvastatina inhibe la HMG-CoA reductasa, lo que provoca una disminución de la síntesis de colesterol y una posible inhibición de la MARCH. | ||||||
Simvastatin, Sodium Salt | 12009-77-6 | sc-222312 | 5 mg | $162.00 | 6 | |
La simvastatina sódica es una forma salina de la simvastatina y actúa a través del mismo mecanismo inhibiendo la HMG-CoA reductasa y reduciendo los niveles de colesterol. | ||||||
Cerivastatin, Sodium Salt | 143201-11-0 | sc-207418 | 2.5 mg | $175.00 | ||
La cerivastatina inhibe la HMG-CoA reductasa, con lo que disminuye la producción de colesterol, lo que puede repercutir en la activación de MARCH. | ||||||
Fluvastatin | 93957-54-1 | sc-279169 | 50 mg | $250.00 | ||
La fluvastatina sódica, una forma salina de la fluvastatina, inhibe la HMG-CoA reductasa, influyendo potencialmente en MARCH a través de la reducción del colesterol. | ||||||
Fluvastatin, Sodium Salt | 93957-55-2 | sc-202613 sc-202613A sc-202613B | 25 mg 50 mg 100 mg | $91.00 $135.00 $241.00 | 1 | |
La lovastatina sódica, una forma salina de la lovastatina, inhibe la HMG-CoA reductasa y afecta indirectamente a la actividad MARCH a través de la reducción del colesterol. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $98.00 $140.00 $306.00 $459.00 $1224.00 $1958.00 | 1 | |
Similar a la talidomida y la lenalidomida, afecta a la actividad de la ubiquitina ligasa. | ||||||